Methodology of metabolic risk factor identification in patients with Stage I abdominal obesity
Aim. To study modifiable and non-modifiable risk factors (RF) of Stage I obesity and metabolic disturbances, related to associated pathology development.Material and methods. Seventy-eight men and 54 women, aged 30-50 years, with abdominal-visceral obesity (body mass index 25-35 kg/m2), without card...
| Egile Nagusiak: | , , , |
|---|---|
| Formatua: | Artikulua |
| Hizkuntza: | Russian |
| Argitaratua: |
«SILICEA-POLIGRAF» LLC
2007-02-01
|
| Saila: | Кардиоваскулярная терапия и профилактика |
| Gaiak: | |
| Sarrera elektronikoa: | https://cardiovascular.elpub.ru/jour/article/view/1159 |
| _version_ | 1827064117919219712 |
|---|---|
| author | M. A. Khasina E. I. Trofimova T. N. Lemeshko O. A. Artyukova |
| author_facet | M. A. Khasina E. I. Trofimova T. N. Lemeshko O. A. Artyukova |
| author_sort | M. A. Khasina |
| collection | DOAJ |
| description | Aim. To study modifiable and non-modifiable risk factors (RF) of Stage I obesity and metabolic disturbances, related to associated pathology development.Material and methods. Seventy-eight men and 54 women, aged 30-50 years, with abdominal-visceral obesity (body mass index 25-35 kg/m2), without cardiovascular disease, underwent questionnaire survey, anthropometry, and blood lipid profile assessment.Results. Eighty per cent of the patients had 9-11 obesity and associated pathology RF, 14% – 4-8 RF, and just 6% – ≤3 RF. Lipid profile disturbances were registered in 92% of men and 89% of women. In men, levels of very lowdensity lipoprotein cholesterol, triglycerides and atherogenicity index were significantly higher. Conclusion. Based on present RF levels, registered in 122 atherosclerosis-free patients with Stage I abdominal obesity, 10-year risk of associated pathology was estimated as moderate (10-20%) in 105 (79%) patients, and mild (5-10%) in 17 (13%) patients. |
| first_indexed | 2024-04-10T03:40:57Z |
| format | Article |
| id | doaj.art-cd307be280b34e699bcd2dc7cf43cd05 |
| institution | Directory Open Access Journal |
| issn | 1728-8800 2619-0125 |
| language | Russian |
| last_indexed | 2025-03-19T22:42:03Z |
| publishDate | 2007-02-01 |
| publisher | «SILICEA-POLIGRAF» LLC |
| record_format | Article |
| series | Кардиоваскулярная терапия и профилактика |
| spelling | doaj.art-cd307be280b34e699bcd2dc7cf43cd052024-10-17T12:21:24Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252007-02-01617983871Methodology of metabolic risk factor identification in patients with Stage I abdominal obesityM. A. Khasina0E. I. Trofimova1T. N. Lemeshko2O. A. Artyukova3Vladivostok State Medical University, VladivostokVladivostok State Medical University, VladivostokVladivostok State Medical University, VladivostokVladivostok State Medical University, VladivostokAim. To study modifiable and non-modifiable risk factors (RF) of Stage I obesity and metabolic disturbances, related to associated pathology development.Material and methods. Seventy-eight men and 54 women, aged 30-50 years, with abdominal-visceral obesity (body mass index 25-35 kg/m2), without cardiovascular disease, underwent questionnaire survey, anthropometry, and blood lipid profile assessment.Results. Eighty per cent of the patients had 9-11 obesity and associated pathology RF, 14% – 4-8 RF, and just 6% – ≤3 RF. Lipid profile disturbances were registered in 92% of men and 89% of women. In men, levels of very lowdensity lipoprotein cholesterol, triglycerides and atherogenicity index were significantly higher. Conclusion. Based on present RF levels, registered in 122 atherosclerosis-free patients with Stage I abdominal obesity, 10-year risk of associated pathology was estimated as moderate (10-20%) in 105 (79%) patients, and mild (5-10%) in 17 (13%) patients.https://cardiovascular.elpub.ru/jour/article/view/1159abdominal obesityrisk factorslipidscardiovascular disease |
| spellingShingle | M. A. Khasina E. I. Trofimova T. N. Lemeshko O. A. Artyukova Methodology of metabolic risk factor identification in patients with Stage I abdominal obesity Кардиоваскулярная терапия и профилактика abdominal obesity risk factors lipids cardiovascular disease |
| title | Methodology of metabolic risk factor identification in patients with Stage I abdominal obesity |
| title_full | Methodology of metabolic risk factor identification in patients with Stage I abdominal obesity |
| title_fullStr | Methodology of metabolic risk factor identification in patients with Stage I abdominal obesity |
| title_full_unstemmed | Methodology of metabolic risk factor identification in patients with Stage I abdominal obesity |
| title_short | Methodology of metabolic risk factor identification in patients with Stage I abdominal obesity |
| title_sort | methodology of metabolic risk factor identification in patients with stage i abdominal obesity |
| topic | abdominal obesity risk factors lipids cardiovascular disease |
| url | https://cardiovascular.elpub.ru/jour/article/view/1159 |
| work_keys_str_mv | AT makhasina methodologyofmetabolicriskfactoridentificationinpatientswithstageiabdominalobesity AT eitrofimova methodologyofmetabolicriskfactoridentificationinpatientswithstageiabdominalobesity AT tnlemeshko methodologyofmetabolicriskfactoridentificationinpatientswithstageiabdominalobesity AT oaartyukova methodologyofmetabolicriskfactoridentificationinpatientswithstageiabdominalobesity |